/

Società

Hi

Non verificato

Hims & Hers

Di cosa scriviamo

FarmaceuticaFitnessSaluteSanitàVetrine/Shopping

68 comunicati stampa

Guarda tutti i comunicati

04/06/2026

Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims

Fonte

Emittente

1.00

0

02/06/2026

Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform

Fonte

Emittente

1.00

0

02/06/2026

Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians

Fonte

Emittente

1.00

0

02/06/2026

Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform

Fonte

Emittente

1.00

0

02/06/2026

Hims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in Germany

Fonte

Emittente

1.00

0

02/06/2026

Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market

Fonte

Emittente

1.00

0

28/05/2026

Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners

Fonte

Emittente

1.00

0

21/05/2026

Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide

Fonte

Emittente

1.00

0

21/05/2026

Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada

Fonte

Emittente

1.00

0

19/05/2026

Tecnica

Tecnologie Varie

Software

Sanità

Farmaceutica

Salute

Information Technology

Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0